Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and ...
Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...
But often the cancer will return and the entire bladder will be removed. “That comes like all kind of the side effects a ...
Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...
Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...
The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...
In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.
The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback